ArticleExperimental and therapeutic medicine2017

Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells.

Eri Takiguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.